• 목록

“This Is How We Beat Cancer”

International Academic Conference on Cancer Treatment at Seoul St. Mary’s Hospital

The International Virus Research Alliance (IVRA) will host an international medical academic conference under the theme “This Is How We Beat Cancer” on Sunday, June 9, 2024, from 9:00 AM to 6:00 PM at the Maria Hall, The Catholic University of Korea Seoul St. Mary’s Hospital. The event will bring together leading international cancer specialists and Korean oncologists to present treatment results and propose new directions in cancer therapy.

The conference will be attended by approximately 200 international cancer experts, 300 Korean medical professionals, as well as cancer patients and their families, making it a significant platform for sharing clinical experiences and providing hope to those battling cancer.

Keynote International Speakers

Distinguished international participants include:

·         Dr. Hassan Basri Jahubar Sathik (Malaysia, Senior Director, Cyberjaya University)

·         Dr. Damodara Kumaran (India, Head of Radiation Clinical Oncology, Krishna Cancer Institute and Cancer Trust Hospitals, Cuddalore & Puducherry)

·         Dr. Nagraj G. Huilgol (India, Chief Radiation Oncologist, Balabhai Nanavati Hospital)

·         Dr. Kenny Yong Yean Sim (Malaysia, Director, Well Again HealthCare Center)

·         Dr. Juliana Samuel (Malaysia, Director, Klinik Famili, Sabah)

·         Dr. Alsharif Ibrahim Ahmed M. (Saudi Arabia, Director, Dar Al Shifa Hospital)

·         Dr. Turki Abdullah Al Mohoud (Saudi Arabia, Group CEO, Dar Al Shefa Medical Group)

Key Korean Presenters

From Korea, prominent speakers include:

·         Dr. Eui-Shin Kim (Lifetime Professor, MD Anderson Cancer Center, USA; Professor, Seoul National University)

·         Prof. Hong-Seok Jang and Prof. Young-Nam Kang (Department of Radiation Oncology, Seoul St. Mary’s Hospital, The Catholic University of Korea)

·         Prof. Il-Bong Choi (Chairman, Korean Society of Hyperthermia in Medicine; Endowed Professor, Jeju National University)

·         Dr. Seung-Mo Yoo (Director, Yesan Myongji Hospital; Chairman, IVRA Korea)

·         Dr. Seon-Man Kim (Director, Amilang Clinic, Suwon)

·         Dr. Hyung-Jin Shin (Director, EM365 Clinic, Hwaseong)

·         Dr. Jae-Ho Yang (Director, ChiHyu Korean Medicine Hospital, Jongno)

·         Dr. Jung-Man Ryu (Director, Navisol Korean Medicine Hospital, Cheongju)

·         Dr. Chan-Yong Lee (Director, OnCare Seoul)

In addition, Mr. Sung-Ho Han, CEO of AdipoLabs, Inc., will explain the principles behind the company’s high-frequency hyperthermia cancer treatment device, highlighting its pain-free therapeutic mechanism.

Conference Chairs

The academic authority of the event will be further strengthened by distinguished chairs, including:

·         Prof. Kang-Hyun Lee (Former Dean, Yonsei University Wonju College of Medicine)

·         Dr. Kyung-Jin Kim (Korean Society of Balance Medicine)

·         Dr. Sang-Keun Jang (Former Director, Konkuk University Hospital)

·         Prof. Hwa-Seung Yoo (Director, Seoul Dongseo Cancer Center, Daejeon University)

Supporting Institutions

The conference is co-sponsored by The Catholic University of Korea Seoul St. Mary’s Hospital, Yonsei University Wonju Severance Hospital, Korean Society of Hyperthermia in Medicine, Korean Emergency Medical Association, Korean Society of Balance Medicine, and Red & Blue, among other domestic and international medical organizations.

Focus of the Conference

Presentations will cover the role of hyperthermia in modern cancer therapy, the clinical effectiveness of high-frequency hyperthermia treatment, and real-world experiences of applying heat-based therapies in cancer management.

IVRA’s Mission

Mr. Sung-Ho Han, CEO of AdipoLabs and concurrently Chairman of IVRA, will present the founding purpose and mission of IVRA, as well as its ongoing activities with member physicians worldwide. He stated:

“Now in its sixth year, the IVRA International Academic Conference will continue to contribute to the long-standing goal of conquering cancer by sharing treatment cases and advancing medical technology through collaboration with renowned scholars at home and abroad.”